Status:
UNKNOWN
Effect of Supplementation With HMB and Glutamine in Wound Healing on Bloody Areas
Lead Sponsor:
Hospital General de Mexico
Conditions:
Wound Healing
Diabetic
Eligibility:
All Genders
18-65 years
Phase:
PHASE4
Brief Summary
A randomized controlled clinical trial in two groups of supplementation with HMB and glutamine. Each group consist in 25 patients with bloody areas, one group will receive and intervention with HMB an...
Detailed Description
A fundamental part of the integral management of wound healing in patients with bloody areas is nutrition, since it involves biochemical events that depend on the substrates it provides. Wound healing...
Eligibility Criteria
Inclusion
- Patients with bloody areas at hospital admission
- Hospital length stay around 15 days
- Medical treatment with surgical washing and negative pressure systems
- For the groups with diabetes, patients with diagnosis of type 2 diabetes with bloody areas.
- Patients that accepts and signs the informative consent.
Exclusion
- patients with cancer or immunodeficiency
- patients with HbA1c \< 12
- patients with collagen disease
- patients with allergy to intervention substances (HMB, glutamine)
Key Trial Info
Start Date :
June 1 2021
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 31 2021
Estimated Enrollment :
30 Patients enrolled
Trial Details
Trial ID
NCT03782155
Start Date
June 1 2021
End Date
December 31 2021
Last Update
September 3 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hospital General de México
Mexico City, Mexico